...
首页> 外文期刊>Journal of critical care >Evaluation of a vancomycin dosing nomogram based on the Modification of Diet in Renal Disease equation in intensive care unit patients
【24h】

Evaluation of a vancomycin dosing nomogram based on the Modification of Diet in Renal Disease equation in intensive care unit patients

机译:基于重症监护患者肾病等式饮食改性的万古霉素给药载体的评价

获取原文
获取原文并翻译 | 示例

摘要

Purpose: The purpose of the study is to evaluate the effectiveness of a vancomycin nomogram using actual body weight and the Modification of Diet in Renal Disease equation to estimate renal function in intensive care unit patients.Methods: Retrospective evaluation (preimplementation group, n = 57) was conducted from March 2011 to April 2011. Prospective evaluation was conducted after nomogram implementation (postimplementation group, n = 60) from December 2011 to February 2012.Results: The percentage of patients with an initial vancomycin trough concentration 15 pglmL or higher increased in the postimplementation group as compared with the preimplementation group (72% vs 39%, P = .0004). The postimplementation group also demonstrated an increase in the percentage of patients with initial trough concentration between 15 and 20 pg/mL (42% vs 19%, P = .0099), and no statistical difference in the percentage of patients with an initial trough greater than 20 /rg/mL (30% vs 19%, P = .2041). There was no difference in nephrotoxicity in the postimplementation group compared with the preimplementation group (18% vs 17.5%, P - 1.0).Conclusion: Use of a vancomycin nomogram increased the percentage of initial vancomycin trough concentrations 15 pg/mL or higher in intensive care unit patients and was not associated with an increased occurrence of nephrotoxicity.? 2013 Elsevier Inc. All rights reserved.
机译:目的:该研究的目的是评估使用实际体重和肾病方程的实际体重和改性饮食的有效性,以估算重症监护病房患者肾功能。方法:回顾性评估(PreSplementation Group,n = 57 )于2011年3月至2011年4月进行。从2011年12月到2012年12月,罗门书执行(Postimplation Group,N = 60)后进行前瞻性评估。结果:初始万古霉素槽浓度15分钟或更高的患者的百分比与PreSplementation组相比的后后期组(72%与39%,P = .0004)。后后期组还证明了初始槽浓度的百分比增加了15至20 pg / ml(42%与19%,p = .0099),并且初始槽的患者百分比没有统计学差异超过20 / rg / ml(30%vs 19%,p = .2041)。与PreSplementation组相比,后后期肾毒性没有差异(18%Vs 17.5%,P - 1.0)。结论:使用万古霉素NOM图的使用增加了初始万古霉素槽浓度15 pg / ml或更高的百分比护理单位患者患者与肾毒性的发生增加无关。? 2013年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号